Chronic kidney disease (CKD) is associated with the development of mineral bone disorder
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …

Abstract Purpose of Review Chronic kidney disease (CKD) is associated with bone loss and
fractures. The purpose of this review is to provide clinicians with an overview of the …

Heavy metals are commonly released into the environment through industrial processes
such as mining and refining. The rapid industrialization that occurred in South Korea during …

Since denosumab-associated hypocalcemia occurs infrequently, data on its incidence and
risk factors are limited. We aimed to evaluate risk factors and develop a useful score for …

Denosumab is a pivotal treatment for postmenopausal women with osteoporosis. Although
its clinical use is generally well tolerated by patients, denosumab in patients with renal …

Background Giant cell tumor is known to be a benign neoplasm that arises most commonly
in the long bones, while cases in the spine are rare. Recently, denosumab, a monoclonal …

Renal insufficiency and bone loss : Current Opinion in Rheumatology Renal insufficiency and
bone loss : Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe …

Chronic kidney disease (CKD) is associated with high rates of fracture, cardiovascular
events, and mortality. The pathophysiology is complex, including reduced levels of Klotho …

BACKGROUND Bisphosphonates are contraindicated in patients with stage 4+ chronic
kidney disease. However, they are widely used to prevent fragility fractures in stage 3 …

Objective To report diagnostic and management challenges of the case of a 91-year-old
male patient with Paget's disease (PD) and secondary hyperparathyroidism due to renal …